CAS 1189944-10-2

Acetildenafil-d8

Controlled Product

CAS: 1189944-10-2

Applications It is a designer drug which acts as a phosphodiesterase inhibitor. It is a structural analogue of Sidenafil (Viagra), which has been detected in numerous different brands of supposedly ”herbal” aphrodisiac products sold to boost libido and alleviate erectile dysfunction.
References Brock, G., et al.: Drugs Today, 36, 125 (2000), Rosen, R., et al.: Am. J. Cardiol., 92, 9 (2003), Shimizu-Albergine, M., et al.: J. Neurosci., 23, 6452 (2003), Venhuis, B.J., et al.: Forensic Sci. International., 177, 25 (2008),

Formula: C₂₅H₂₆D₈N₆O₃

Color and Shape: Neat

Molecular weight: 474.63

Ref: TR-A161602

Acetildenafil-d8

CAS: 1189944-10-2

Acetildenafil-d8 is an analog of sildenafil that has been shown to induce apoptosis in cancer cells. It works by inhibiting kinases, which are enzymes that play a critical role in regulating cell growth and division. Acetildenafil-d8 has been detected in urine samples from Chinese patients with cancer, indicating its potential use as an anticancer agent. This compound has also been found to be a potent inhibitor of protein kinases, which are involved in the regulation of various cellular processes. In preclinical studies, Acetildenafil-d8 has demonstrated significant activity against tumor growth and proliferation. In addition, it has been reported to have synergistic effects when combined with other kinase inhibitors such as donepezil. Overall, Acetildenafil-d8 shows great promise as a potential therapeutic agent for the treatment of cancer.

Formula: C₂₅H₃₄N₆O₃

Purity: Min. 95%

Molecular weight: 474.6 g/mol

Ref: 3D-PXB94410